These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 16330815)
1. A fundamental bimodal role for neuropeptide Y1 receptor in the immune system. Wheway J; Mackay CR; Newton RA; Sainsbury A; Boey D; Herzog H; Mackay F J Exp Med; 2005 Dec; 202(11):1527-38. PubMed ID: 16330815 [TBL] [Abstract][Full Text] [Related]
2. NPY and receptors in immune and inflammatory diseases. Wheway J; Herzog H; Mackay F Curr Top Med Chem; 2007; 7(17):1743-52. PubMed ID: 17979783 [TBL] [Abstract][Full Text] [Related]
3. Role of the Y1 receptor in the regulation of neuropeptide Y-mediated feeding: comparison of wild-type, Y1 receptor-deficient, and Y5 receptor-deficient mice. Kanatani A; Mashiko S; Murai N; Sugimoto N; Ito J; Fukuroda T; Fukami T; Morin N; MacNeil DJ; Van der Ploeg LH; Saga Y; Nishimura S; Ihara M Endocrinology; 2000 Mar; 141(3):1011-6. PubMed ID: 10698177 [TBL] [Abstract][Full Text] [Related]
4. A neuropeptide in immune-mediated inflammation, Y? Prod'homme T; Weber MS; Steinman L; Zamvil SS Trends Immunol; 2006 Apr; 27(4):164-7. PubMed ID: 16530483 [TBL] [Abstract][Full Text] [Related]
5. The homeostatic role of neuropeptide Y in immune function and its impact on mood and behaviour. Farzi A; Reichmann F; Holzer P Acta Physiol (Oxf); 2015 Mar; 213(3):603-27. PubMed ID: 25545642 [TBL] [Abstract][Full Text] [Related]
6. The Y1 receptor for NPY: a key modulator of the adaptive immune system. Wheway J; Herzog H; Mackay F Peptides; 2007 Feb; 28(2):453-8. PubMed ID: 17240480 [TBL] [Abstract][Full Text] [Related]
7. Energy metabolic profile of mice after chronic activation of central NPY Y1, Y2, or Y5 receptors. Henry M; Ghibaudi L; Gao J; Hwa JJ Obes Res; 2005 Jan; 13(1):36-47. PubMed ID: 15761161 [TBL] [Abstract][Full Text] [Related]
8. Increased brain neuropeptide Y1 and Y2 receptor binding in NPY knock out mice does not result in increased receptor function. Gehlert DR; Shaw JL Peptides; 2007 Feb; 28(2):241-9. PubMed ID: 17208335 [TBL] [Abstract][Full Text] [Related]
9. Neuropeptide Y: a new mediator linking sympathetic nerves, blood vessels and immune system? Zukowska Z; Pons J; Lee EW; Li L Can J Physiol Pharmacol; 2003 Feb; 81(2):89-94. PubMed ID: 12710520 [TBL] [Abstract][Full Text] [Related]
10. Combined deletion of Y1, Y2, and Y4 receptors prevents hypothalamic neuropeptide Y overexpression-induced hyperinsulinemia despite persistence of hyperphagia and obesity. Lin EJ; Sainsbury A; Lee NJ; Boey D; Couzens M; Enriquez R; Slack K; Bland R; During MJ; Herzog H Endocrinology; 2006 Nov; 147(11):5094-101. PubMed ID: 16873543 [TBL] [Abstract][Full Text] [Related]
11. Neuropeptide Y and its receptor subtypes specifically modulate rat peritoneal macrophage functions in vitro: counter regulation through Y1 and Y2/5 receptors. Dimitrijević M; Stanojević S; Vujić V; Beck-Sickinger A; von Hörsten S Regul Pept; 2005 Jan; 124(1-3):163-72. PubMed ID: 15544855 [TBL] [Abstract][Full Text] [Related]
12. Attenuation of acute experimental colitis by preventing NPY Y1 receptor signaling. Hassani H; Lucas G; Rozell B; Ernfors P Am J Physiol Gastrointest Liver Physiol; 2005 Mar; 288(3):G550-6. PubMed ID: 15499082 [TBL] [Abstract][Full Text] [Related]
13. NPY-Y1 coexpressed with NPY-Y5 receptors modulate anxiety but not mild social stress response in mice. Longo A; Oberto A; Mele P; Mattiello L; Pisu MG; Palanza P; Serra M; Eva C Genes Brain Behav; 2015 Sep; 14(7):534-42. PubMed ID: 26178014 [TBL] [Abstract][Full Text] [Related]
14. The ability of neuropeptide Y to mediate responses in the murine cutaneous microvasculature: an analysis of the contribution of Y1 and Y2 receptors. Chu DQ; Cox HM; Costa SK; Herzog H; Brain SD Br J Pharmacol; 2003 Sep; 140(2):422-30. PubMed ID: 12970079 [TBL] [Abstract][Full Text] [Related]
15. Y1 signalling has a critical role in allergic airway inflammation. Macia L; Rao PT; Wheway J; Sierro F; Mackay F; Herzog H Immunol Cell Biol; 2011 Nov; 89(8):882-8. PubMed ID: 21383768 [TBL] [Abstract][Full Text] [Related]
16. Mitogenic actions of neuropeptide Y in vascular smooth muscle cells: synergetic interactions with the beta-adrenergic system. Pons J; Kitlinska J; Ji H; Lee EW; Zukowska Z Can J Physiol Pharmacol; 2003 Feb; 81(2):177-85. PubMed ID: 12710532 [TBL] [Abstract][Full Text] [Related]
17. Differential actions of NPY on seizure modulation via Y1 and Y2 receptors: evidence from receptor knockout mice. Lin EJ; Young D; Baer K; Herzog H; During MJ Epilepsia; 2006 Apr; 47(4):773-80. PubMed ID: 16650144 [TBL] [Abstract][Full Text] [Related]
18. Cloning and characterization of rabbit neuropeptide Y receptor subtypes. Umeda T; Kanatani A; Iwaasa H Peptides; 2009 Aug; 30(8):1441-7. PubMed ID: 19481128 [TBL] [Abstract][Full Text] [Related]
19. Identification and distribution of mRNA encoding the Y1, Y2, Y4, and Y5 receptors for peptides of the PP-fold family in the rat intestine and colon. Goumain M; Voisin T; Lorinet AM; Laburthe M Biochem Biophys Res Commun; 1998 Jun; 247(1):52-6. PubMed ID: 9636652 [TBL] [Abstract][Full Text] [Related]
20. Evidence that stimulation of two modalities of pituitary luteinizing hormone release in ovarian steroid-primed ovariectomized rats may involve neuropeptide Y Y1 and Y4 receptors. Jain MR; Pu S; Kalra PS; Kalra SP Endocrinology; 1999 Nov; 140(11):5171-7. PubMed ID: 10537146 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]